New malaria vaccine shows promise in early clinical trial

A malaria vaccine remains the most desired tool to combat the worsening malaria epidemic in many developing countries. Pierre Druilhe and colleagues (from the Institut Pasteur in Paris) have completed the first human trial of a vaccine based on MSP3, a protein present on the surface of the malaria parasite, with very encouraging results.

As the researchers report in the international open-access medical journal PLoS Medicine, most of the 30 healthy volunteers who received the vaccine developed strong, specific, and in some cases long-lasting immune responses against the MSP3 protein.

However, as researchers have learned from many early HIV and malaria vaccine trials, the crucial question is whether these immune responses mean that vaccinated people are actually protected against malaria. The straightforward way to test this is to expose the vaccinated trial participants to malaria and see if they are protected. However, this risky test is not ethical during the early stages of vaccine testing.

But Druilhe and colleagues were nevertheless able to take their early trial a step further: They demonstrated that antibodies from the blood of vaccinated volunteers were able to inhibit growth of the malaria parasite in two independent laboratory assays.

"A particular strength of the MSP3 trial is that functional assays [tests to see whether the vaccine could kill parasites] were utilized to assess the quality of the antibody response produced," say Brendan Crabb and James Beeson in an accompanying Perspective. However, they also point out that important questions remain, some of which will only be answered in additional clinical trials. Based on the results described in the PLoS Medicine article, Druilhe and colleagues have started a Phase II efficacy field trial of the MSP3 vaccine in malaria-exposed individuals.


Contact: Paul Ocampo
Public Library of Science

Page: 1

Related medicine news :

1. Bias in statin trials, failure to control malaria, and more
2. HIV and malaria combine to adversely affect pregnant women and their infants
3. Certain combination therapy found more effective for treating malaria in African children
4. Article outlines current recommendations for treating malaria in the US
5. Diagnostic tests for malaria underused in Zambia
6. Nearly half of children in Kenya with common type of severe malaria affected neurologically
7. Antifolate therapies found effective against certain type of malaria
8. Global Fund must fund salaries of health workers to deliver HIV, TB and malaria treatments
9. NIAID media availability: Examining genetic variability of malaria parasite offers insight
10. Global malaria map key weapon in fight against malaria, scientists say
11. Individualized strategies needed for prevention of malaria in long-term travelers

Post Your Comments:

(Date:11/19/2019)... FRISCO, Texas (PRWEB) , ... November 19, 2019 , ... ... celebration for their second full-service Emergency Room and Urgent Care facility on November 20th, ... located on Eldorado Parkway just east of the Dallas North Tollway , Medco provides ...
(Date:11/19/2019)... ... November 19, 2019 , ... After the closure of the ... to conduct an auction of the medical assets. A “decline in community demand” ultimately ... doors. An array of high-end equipment ranging from hospital beds to radiology makes this ...
(Date:11/16/2019)... ... 2019 , ... MemoryCare.com , a comprehensive resource for ... Care Facilities in Medford, Oregon. The guide identifies 3 memory care communities based ... the Alzheimer’s Association , 5.6 million people age 65 and older are ...
(Date:11/15/2019)... ... November 15, 2019 , ... Anxiety is sweeping the ... puts the current figures of adults who suffer at 40 million, yet ... manifest in many different ways, including Post Traumatic Stress Disorder (PTSD), phobias, Generalized ...
(Date:11/14/2019)... ... 14, 2019 , ... With Giving Tuesday on Dec. 3, ... and organizations about the benefits of supporting local hospitalized veterans throughout Maryland. Created ... of people to give, collaborate and celebrate generosity before the holidays, and enables ...
Breaking Medicine News(10 mins):
(Date:11/19/2019)... ... November 19, 2019 , ... As the Capillus® family of brands ... a name change. The Florida company is now Curallux, LLC. The change was inspired ... The new name, “Curallux”, stems from Latin words for “healing” and “light”. , The ...
(Date:11/19/2019)... COUNTY, N.Y. (PRWEB) , ... November 19, 2019 , ... ... hospices hosted their 10th annual inter-hospice countywide breakfast on Tuesday, November 12. The event, ... served in all five branches of the military: Army, Navy, Air Force, Marines and ...
(Date:11/19/2019)... ... November 18, 2019 , ... San Antonio-based businesses, ... Cannabidiol (CBD) product sales through a new partnership announced today. This collaboration has ... CBD products. , A selection of Rodkeys branded non-THC CBD products are now ...
Breaking Medicine Technology:
Cached News: